Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2003

View Archived Issues

Safety of Sch-55700 in patients with severe persistent asthma

Transient antitumor effects of tipifarnib in hematological malignancies

Good safety and tolerability profile described for entecavir in hepatitis B

Beta-L-Fd4C versus lamivudine and placebo for reducing viral load in patients with HBV infection

Exemestane beneficial in cirrhotic patients with hypogonadism

Treatment failure on ISIS-14803 and HCV resistance

Activated recombinant factor VII may improve bleeding control in cirrhosis

Trichostatin A potentiates the proapoptotic effects of biomodulators on hepatocellular carcinoma

Activation of CB2 receptors induces apoptosis of hepatic myofibroblasts in vitro

Human arginase II: a possible target for the treatment of sexual arousal disorders

Selective MMP-3 inhibitor as a candidate therapeutic for chronic dermal wounds

Stent-induced restenosis reduced by inhibitor of PDGFR-TK

Spotlight on glycyrrhizin, an active component of licorice root

Use of Y5 receptor antagonists in CNS disorders such as depression

HuMax-CD20 effective in depleting B-cells in primate study

Vasogen initiates patient enrollment in pivotal ACCLAIM trial

PT-100 and Rituxan combination trial under way

EMEA approves Pfizer's Genotropin

FDA approves Infanrix fifth dose indication

Immune Response evaluates second-generation HIV vaccine

Ortho-McNeil reveals new erythromycin derivatives

Factor Xa inhibitors and their application described by Lilly

BMS identifies series of HIV integrase inhibitors

Recent Merck patents cover pyrimidinone KSP inhibitors

Second phase of landmark rheumatoid arthritis study program enrolls 5,000 patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...